SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-178106
Filing Date
2022-06-22
Accepted
2022-06-22 06:22:34
Documents
12
Period of Report
2022-06-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d356525d8k.htm   iXBRL 8-K 24498
  Complete submission text file 0001193125-22-178106.txt   142667

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enta-20220621.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20220621_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20220621_pre.xml EX-101.PRE 10811
6 EXTRACTED XBRL INSTANCE DOCUMENT d356525d8k_htm.xml XML 3279
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 221029916
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences